Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Commitments and Other (Details Textual)

v3.5.0.2
Note 11 - Commitments and Other (Details Textual)
3 Months Ended 9 Months Ended
Jan. 01, 2005
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
ft²
shares
Sep. 30, 2015
USD ($)
Director of Clinical Affairs [Member]          
Stock Issued During Period, Shares, Stock Options Exercised Attributable to Consultants | shares       8,333  
Royalty Expense   $ 148,185 $ 117,320 $ 449,875 $ 313,751
Professional Fees   68,751 39,300 $ 206,253 117,900
Lease Expiration Date       Jan. 31, 2020  
Area of Office Space | ft²       7,625  
Operating Leases, Rent Expense, Minimum Rentals       $ 12,522  
Operating Leases, Rent Expense   25,031 18,941 95,019 56,693
Payments for Postemployment Benefits       $ 203,111  
Define Benefit Plan, Payment Period       5 years  
Pension Expense   $ 50,777 $ 50,778 $ 152,000 $ 152,000
Additional Percentage of Director Compensation on Sales Value Using Certain Specify Technology 2.50%        
Additional Percentage of Director Compensation Sales Value Using Other Kind of Technology 5.00%